-
Vaccines have saved millions of lives and their benefits far outweigh the possible risks from the medical side-effects
-
AZ admitted that the vaccine developed with the University of Oxford to protect against COVID-19 may cause Thrombosis with Thrombocytopenia Syndrome (TTS) in “very rare cases”.
-
In fact, the study found that there were less chances of death after heart attack in vaccinated individuals.
-
In mid-May 2021 the Ministry of Health & Family Welfare raised red-flags on both Covaxin and Covishield that were being jabbed into millions of countrymen, initially free of cost
-
The company already has six million booster doses of Covovax vaccine available and adults must take the booster shot, said CEO Adar Poonawalla
-
New Delhi: The Central government has approved Biological E’s Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday. On Tuesday, ANI had reported that Corbevax booster for heterologous first has been approved by the Centre. Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological […]
-
Hyderabad: The State government on Tuesday urged Union Minister of Health and Family Welfare (MOHFW), Dr Mansukh Mandaviya to urgently release 50 lakh doses of Covishield vaccine to Telangana, which will help to ramp up the pace of the ongoing drive to administer precautionary/ booster doses. In a letter to Dr Mandaviya, the State Health […]
-
Hyderabad: A day before Covid vaccine booster shots become available to all adult population, prices of Covaxin and Covidshield have been reduced to Rs 225 per dose for private hospitals. Suchitra Ella, Co-Founder and Joint Managing Director of Covaxin maker Bharat Biotech announced the decision on the micro-blogging platform Twitter. “We welcome the decision to […]
-
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting besides recording all vaccinations done within the country on the CoWIN platform, the sources said.
-
Hyderabad: Burglars broke into an Urban Primary Health Centre at Kalikhabar in the old city and decamped with 41 vials of Covishield and Covaxin on Sunday. According to the police, the burglars broke open the main door of the UPHC Jambagh on the Kalikhabar road under the Mirchowk police station limits and entered the premises. […]
-
Hyderabad: The administration of booster dose of Covid vaccines to senior citizens with comorbidities, healthcare and frontline workers in Telangana is all set to start from Monday, with the Health Department completing the related arrangements at all government Covid vaccination centres. Based on the estimates from the Health Department, a total of 41.60 lakh senior […]
-
Hyderabad: According to the announcement made by the Central government, appointments for the precautionary dose of the Covid-19 vaccine in India will begin from Saturday evening. te. The eligible population – healthcare workers, frontline workers, and those above 60 years of age with comorbidities – who have already taken two doses of the vaccine, can […]
-
New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech’s application for clinical trials of its intranasal Covid vaccine as a booster or a third dose. The Hyderabad-based manufacturer has proposed the booster dose for those who have been […]
-
Hyderabad: A mix and match of Covishield and Covaxin has the ability to elicit a robust antibody response against SARS-CoV-2, a pilot study taken-up by city-based Asian Institute of Gastroenterology (AIG) Hospitals on Monday said. The AIG study also has indicated that 87 percent of the participants in the study, who were not vaccinated and […]
-
Hyderabad: The Omicron variant driven Covid third wave in the country is expected to last for four months with infections gradually beginning to surge in January and February and peak in the early weeks of March before the numbers dip by the end of April. The updated SUTRA mathematical projection of pandemics, developed by researchers […]
-
Pune: Eminent scientist and Executive Director of Serum Institute of India (SII) Dr Suresh S. Jadhav – who was instrumental in developing the lifesaver Covishield vaccine – passed away after a prolonged illness at a private hospital late on Tuesday night. He was 72 and is survived by his wife and two children. Jadhav’s demise […]
-
Hyderabad: Health Minister T Harish Rao has urged Union Minister for Health and Family Welfare Dr Mansukh Mandaviya to reduce the period between the two doses of Covishield vaccine and allow booster doses to be administered to frontline workers, healthcare workers and high-risk groups in Telangana. Harish Rao, in a letter to the Union Minister […]
-
The resurgence of Covid-19 in Europe and the United States and the fear of a similar surge in infections during the months of winter have fuelled the demand for booster Covid vaccines in India. In a desperate attempt to contain the surge, many countries in Europe have gone into lockdown and have also launched massive […]
-
New Delhi: As of now as many as 110 countries have recognized India’s Covid vaccines Covishield and Covaxin and have agreed to mutual recognition of Covid-19 vaccination certificates with India, said official sources in the Union Health Ministry. A source with the Ministry said that at present, 110 countries have agreed to mutual recognition of […]
-
After the prolonged wait and conflicting signals, the World Health Organization’s approval for the indigenous Covid-19 vaccine, Covaxin, brings much-needed relief and reflects global acknowledgement of India’s scientific prowess and research credentials. More importantly, it paves the way for its widespread distribution around the world and brightens the chances for the company’s vaccine for children […]
